Fusion Biotech

Ulsan, South Korea Founded: 2019 • Age: 7 yrs
Protein-based drugs are developed for degenerative and intractable diseases.
Request Access
Report Incorrect Data
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 3 Services tracked
Competitors - Brand Intelligence

About Fusion Biotech

Fusion Biotech is a company based in Ulsan (South Korea) founded in 2019 by Chaekyu Kim. Fusion Biotech offers products and services including Fusion Protein-Drug Conjugates, Fusion Nanotherapeutics, and Fusion Protein Therapeutics.

  • Headquarter Ulsan, South Korea
  • Founders Chaekyu Kim
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Legal Name (주)퓨전바이오텍
  • Jurisdiction Na, Maharashtra, India
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics → →
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Fusion Biotech

Fusion Biotech offers a comprehensive portfolio of products and services, including Fusion Protein-Drug Conjugates, Fusion Nanotherapeutics, and Fusion Protein Therapeutics.

Primary

Platform for targeted drug delivery to treat diseases effectively

Advanced targeted nano drug complexes for enhanced therapy

Long-lasting bio better proteins for sustained treatment

Funding Insights of Fusion Biotech

Investments & Acquisitions by Fusion Biotech

Investments

Financial Statements - Fusion Biotech

Fusion Biotech Comparisons

+
Add Comparison
Available on Premium

Competitors of Fusion Biotech

Latest news on Fusion Biotech

Frequently Asked Questions about Fusion Biotech

Fusion Biotech was founded in 2019.

Fusion Biotech is headquartered in Ulsan, South Korea.

Fusion Biotech was founded in 2019 in Ulsan, South Korea, within the biotechnology sector. Protein-based drugs are developed by the company to address degenerative and intractable diseases. Technology enabling drugs to dock with fusion proteins has been established, supporting therapeutic advancements. Operations center on research and drug development, with a focus on innovative protein fusion applications in healthcare.

Fusion Biotech offers Fusion Protein-Drug Conjugates, Fusion Nanotherapeutics, and Fusion Protein Therapeutics.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available